Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 02/27 04:14:59 pm
119.43 USD   -0.45%
02/11 VERTEX PHARMACE : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
01/28 VERTEX PHARMACE : 4Q loss is deeper than expected
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
117.12(c) 116.92(c) 118.84(c) 119.97(c) 119.43(c) Last
1 262 645 1 011 019 1 651 106 1 303 281 1 029 433 Volume
-1.26% -0.17% +1.64% +0.95% -0.45% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
03/03 | 10:40amPresentation
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 1 092 M
EBIT 2015 -279 M
Net income 2015 -402 M
Finance 2015 570 M
Yield 2015 -
Sales 2016 2 866 M
EBIT 2016 1 238 M
Net income 2016 1 043 M
Finance 2016 1 790 M
Yield 2016 -
PER 2015 -
PER 2016 33,57
EV / Sales 2015 26,0x
EV / Sales 2016 9,46x
Capitalization 28 913 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
02/26 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Release New Data ..
02/20 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/12 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry from Vertex Pharmac..
02/11 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
02/01 DEUTSCHE BANK : Vertex Pharmaceuticals PT Raised to $155.00 at Deutsche Bank (VR..
01/28 VERTEX PHARMACEUTICALS : 4Q loss is deeper than expected
01/28 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2014 Financial Res..
More news
Sector news Biopharmaceuticals
05:01a SALIX PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Commences An Investigati..
02/27 JOHNSON & JOHNSON : Announces Formation of New Health and Wellness Platform Desi..
02/27 ABBOTT LABORATORIES : Mylan closes $5.3B tax-lowering deal with Abbott Labs
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF